InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Tambiah, Jeyanesh. Director active across 1 company, notably Eupraxia Pharmaceuticals Inc.. In total, 2 filings have been logged. History available since 25 June 2026. The latest transaction was disclosed on 25 June 2026 (50 - Grant of options). Regulator: SEDI. The full history is openly available.
2 of 2 declarations